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Abstract. SEC16 is required for transport vesicle bud- 
ding from the ER in Saccharomyces cerevisiae,  and en- 
codes a large hydrophilic protein found on the ER 
membrane and as part of the coat of transport vesicles. 
In a screen to find functionally related genes, we iso- 
lated SED4 as a dosage-dependent suppressor of tem- 
perature-sensitive SECl6 mutations. Sed4p is an integral 
ER membrane protein whose cytosolic domain binds to 
the COOH-terminal domain of Secl6p as shown by 
two-hybrid assay and coprecipitation. The interaction 
between Sed4p and Secl6p probably occurs before 
budding is complete, because Sed4p is not found in 
budded vesicles. Deletion of SED4 decreases the rate 
of ER to Golgi transport, and exacerbates mutations 
defective in vesicle formation, but not those that affect 
later steps in the secretory pathway. Thus, Sed4p is im- 
portant, but not necessary, for vesicle formation at 
the ER. 
Secl2p, a close homologue of Sed4p, also acts early in 
the assembly of transport vesicles. However, SEC12 
performs a different function than SED4 since Secl2p 
does not bind Secl6p, and genetic tests show that 
SEC12 and SED4 are not functionally interchangeable. 
The importance of Sed4p for vesicle formation is un- 
derlined by the isolation of a phenotypically silent mu- 
tation, sarl-5, that produces a strong ER to Golgi 
transport defect when combined with sed4 mutations. 
Extensive genetic interactions between SAR1, SED4, 
and SEC16 show close functional links between these 
proteins and imply that they might function together as 
a multisubunit complex on the ER membrane. 
T 
HE  transport  of  proteins  between  successive  or- 
ganelles  of the  secretory pathway is  mediated  by 
vesicle carriers that bud from the membrane of the 
donor compartment and then fuse with the membrane of 
the acceptor compartment (Palade, 1975).  A  general fea- 
ture  of vesicle formation is  the  recruitment  of proteins 
from the  cytoplasm to the  membrane for assembly of a 
coat on the budding vesicle (Pearse and Robinson, 1990; 
Rothman  and  Orci,  1992).  In Saccharomyces  cerevisiae, 
seven proteins have been identified by genetic and bio- 
chemical methods that  are  required  for vesicle budding 
from the ER (Novick et al., 1980; Nakano and Muramatsu, 
1989;  Kaiser  and  Schekman,  1990;  Hicke  et  al.,  1992; 
Salama et al., 1993). Five of these proteins (Secl3p, Sec31p, 
Sec23p, Sec24p, and Sarlp) when added in soluble form to 
ER membranes will drive vesicle budding (Salama et al., 
1993; Barlowe et al.,  1994). Under the appropriate condi- 
tions, the vesicles that form have a coat that contains all 
five proteins  (Barlowe  et  al.,  1994).  We recently found 
that a sixth protein, Secl6p, is also a vesicle coat protein 
(Espenshade et al., 1995). However, Secl6p is unlikely to 
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be recruited to the vesicle from the cytoplasm since there 
is no soluble cytoplasmic pool of Secl6p. Instead, Secl6p 
adheres tightly to the ER membrane and may form a pe- 
ripheral membrane scaffold onto which cytosolic coat pro- 
teins assemble (Espenshade et al., 1995). 
An important mechanistic problem is how coat assem- 
bly on the ER membrane is regulated so that vesicle for- 
mation occurs at the proper time and place. Secl2p is a po- 
tential early regulator of vesicle assembly because Sec12p 
resides in the ER membrane and is required for vesicle 
formation, but is not incorporated into the finished vesicle 
structure  (Nakano  et  al.,  1988;  Rexach  and  Schekman, 
1991;  Barlowe et al.,  1994).  The cytosolic, NHE-terminal 
domain of Sec12p catalyzes exchange of GTP for GDP on 
the 21-kD GTPase Sarlp (Barlowe and Schekman, 1993). 
Overexpression of Secl2p increases the amount of Sarlp 
that can be bound to ER membranes in vitro, suggesting 
that Sec12p can recruit Sarlp to the ER membrane (d'En- 
fert  et  al.,  1991b).  Sarlp-GTP  at  the  ER  membrane  is 
thought to then initiate assembly of coat proteins on the 
forming vesicle (Barlowe et al.,  1994;  Oka and Nakano, 
1994). 
S. cerevisiae has a second gene, SED4, that is closely re- 
lated  to SEC12.  The NHe-terminal, cytosolic domain of 
Secl2p shares 45% amino acid identity with Sed4p, but the 
luminal domains of these proteins appear unrelated (Hard- 
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SED4 is involved in vesicular transport, although the step 
in the secretory pathway where SED4 functions has been 
difficult to establish. Deletion of SED4 does not cause a 
pronounced growth or secretion defect, and although SED4 
was  isolated  as  a  multicopy suppressor  of a  deletion  of 
ERD2, the gene encoding the HDEL receptor in yeast, the 
mechanism of this suppression is not understood  (Hard- 
wick et al., 1992). 
We became interested in the action of SED4 in vesicular 
transport when we isolated SED4 as a multicopy suppres- 
sor of sec16 mutations. In this report, we show that SED4 
is involved in ER to Golgi transport and probably func- 
tions in conjunction with Secl6p and Sarlp in an early step 
in vesicle formation. Furthermore, we found that although 
Sed4p  and  Secl2p  are  similar in  structure  and  location, 
these  proteins  appear to  engage  in  functionally  distinct 
processes. 
Materials and Methods 
Strains, Media, and Microbiological  Techniques 
S. cerevisiae strains are listed in Table I. Yeast media (rich medium [YPD]% 
minimal medium, and synthetic complete medium [SC]) were prepared, 
and yeast genetic and molecular biological techniques were performed us- 
ing standard methods (Kaiser et al., 1994).  Yeast transformations were 
carried out using the lithium acetate method (Gietz and Schiestl, 1991). 
Transformants were selected on SC medium lacking the appropriate auxo- 
trophic supplement. All experiments on plasmid-bearing strains were per- 
formed  on  at  least  two  independent  transformants. To  assay loss  of 
URA3-marked plasmids, 105 cells were plated on SC medium containing 
0.1% 5-fluoroorotic acid (Boeke et al., 1984). 
Molecular Biological Techniques 
DNA manipulations, subcloning, and Southern blotting were carried out 
using standard  methods  (Sambrook  et  al.,  1989).  DNA  hybridizations 
were performed using the ECL nucleic acids detection system (Amersham 
Corp., Arlington Heights, IL). DNA sequencing was performed using the 
Sequenase kit (United States Biochemical Corp., Cleveland, OH). Site- 
directed  mutagenesis  was  performed  using  the  protocol  of  Kunkel 
(Kunkel et al., 1987). PCR was carried out using Taq polymerase (Perkin- 
Elmer Cetus, Norwalk, CT). 
Isolation and Analysis of  Multicopy Suppressors 
of sec  l 6 
The YEp24 library (Carlson and Botstein, 1982)  contains genomic inserts 
in a vector carrying the S. cerevisiae URA3 gene and the 21-~  origin of repli- 
cation. Two temperature-sensitive (Ts) sec16 strains, CKY50 and CKY52, 
were transformed with YEp24 library DNA. A  total of 35,000 (CKY50) 
and 13,000 (CKY52) transformants at a density of 1.5 x  103 to i  x  104 col- 
onies per plate were replica plated and incubated at restrictive tempera- 
tures of 30, 33, and 36°C (CKY50) or 33 and 36°C (CKY52). Plasmids iso- 
lated from temperature-resistant colonies were tested for the ability to 
confer the temperature-resistant phenotype. A group of overlapping plas- 
raids conferred growth up to 33 (CKY50) and 36°C (CKY52) and repre- 
sented  the  strongest  suppressor  locus.  The  corresponding  gene  was 
mapped to the right arm of chromosome III near the SED4 open reading 
frame by hybridizing an internal restriction fragment to a Southern blot of 
S. cerevisiae chromosomes (Clontech, Palo Alto, CA) and to a set of or- 
dered yeast genomic clones (Riles et al., 1993). The suppressing gene was 
shown to be SED4 by subcloning fragments into pRS306-2~ and testing 
for their ability to confer temperature resistance to CKY50. 
1. Abbreviations  used in this paper:  aa, amino acid; CPY, carboxypepti- 
dase Y;  GST, glutathione-S-transferase; HA, hemagglutinin; HSP,  high 
speed pellet; nt, nucleotide; SC, synthetic complete medium; Ts, tempera- 
ture-sensitive; YPD, rich yeast medium. 
Plasmid Constructions 
Plasmids are summarized in Table II. p5007 is a YEp24 library plasmid 
containing SED4.  pRH26 is the 7.4-kb ApaI-SalI fragment of p5007 in 
pRS306-21 x. pRH46 is the 5.2-kb SacI-SalI fragment of pRH26 in pRS306- 
2p..  pRH107, pRH67,  and pPE87  are the 5.2-kb Sacl-SalI  fragment of 
pRH46 in pRS316, pRS306, and pRS305-2p., respectively, pRH121  and 
pRH120 are the 5.2-kb SacI-SalI  fragments of pRH117  (see below)  in 
pRS316 and pRS306-2~, respectively. 
Plasmids  carrying  truncations  of  SED4  were  obtained  as  follows: 
pRH26 was cut with SpeI  and the 11.6-kb fragment was self-ligated to 
make pRH47, pRH46 was cut with ApaLI, the 5' overhang was filled in, a 
3.5-kb fragment was purified and cut with SacI-ApaI to produce a 1.8-kb 
fragment that was ligated into SacI-SmaI-cut pRS316-21x to make pRH54. 
pRH77 contains the 1.2-kb XhoI-SspI fragment of pRH46 ligated into 
XhoI-SmaI-cut pRS306-2p., pRH78 contains the 1.2-kb XhoI-SpeI frag- 
ment of pRH77 ligated into XhoI~SpeI-cut pRH26, pRH46 was cut with 
HindIII and the ll-kb fragment was self-ligated to make pRH128, pRH62 
was constructed using two PCR steps (Horton et al., 1989; Yon and Fried, 
1989).  PCR  primers used were  5'-TTG TAA ATA AAG CCG  TGC 
ACA T]?G TGC T]?A TAG GAG AAC TGT AA-3' (nucleotides [nt] 
1124-1101, SED4; and nt 1125-1104, SEC12,  underlined), 5'-GGG AT]? 
ACT TCT ATG GAT G-3' (nt 802-820, SEC12) and 5'-GAT GAA GAT 
GAA  GAC  GGC-3'  (nt  1932-1949,  SED4),  templates  used  were 
pSEC1230 (Nakano et al., 1988)  and pRH46. The PCR product was cut 
with SalI-EcoRI and inserted into SalI-EcoRI cut pRH50 (see below) to 
make pRH56, pRH62 is the 2.5-kb EcoRI fragment of pRH46 ligated into 
EcoRI-cut pRH56, pRH141 is the 2.6-kb EcoRI fragment of pRHll7 (see 
below) ligated into EcoRI-cut pRH62, pRH148 is the 5.2-kb XhoI-Sacl 
fragment of pRH141 in pRS316. 
pRH50  and  pRH213  are  the  3.5-kb  XhoI-HindIII  fragments  of 
pSEC1230 in pRS306-2tx and pRS316, respectively. 
Epitope Tagging SED4 and SEC12 
SED4 was tagged with the hemagglutinin (HA) epitope (Kolodziej and 
Young, 1991) as follows: a single copy of the HA epitope was inserted be- 
fore the COOH-terminal HDEL sequence of SED4 using site-directed 
mutagenesis, resulting in SED4-HA1. The mutagenic oligomer consisted 
of 27 nt encoding the HA epitope (underlined) flanked by 20 and 27 nt 
complementary to the SED4 sequence on the 5' and 3' end respectively 
(5'-CCG TAA ACT ACG CTG GCC "IT]? ACC CAT ACG ACG TCC 
CAG ACT ACG CTC ATG ACG AAT TGT GAA TAA CGA AAT 
AA-3'). Tandem repeats of the HA epitope were inserted by introducing 
a NotI site between the last nucleotide of the HA tag and the COOH-ter- 
minal HDEL sequence by site-directed mutagenesis. The mutagenic oli- 
gomer consisted of a NotI site (underlined) flanked by sequences comple- 
mentary to SED4-HA1 (5'-GAC GTC CCA GAC TAC GCT AGC GGC 
CGC CAT GAC GAA TTG TGA ATA ACG-3'). A cassette containing 
three HA epitopes (Tyers et al., 1993)  was then inserted into the newly 
created NotI site, creating pRH117. By DNA sequencing, pRH117 encodes 
SED4 containing seven tandem repeats of the HA epitope (SED4-HA). 
The NH2-terminal domain of SED4 was placed under control of the 
GALIO promoter and tagged at its 3'  end with a  c-myc epitope  (myc) 
(Munro and Pelham, 1987)  as follows: pCD43  is pRS316 with a  0.6-kb 
EcoRI-BamHI fragment containing the GAL1/GALIO promoter region 
inserted into the polylinker. A  1-kb fragment encoding amino acids (aa) 
1-346 of SED4 plus a Notl site was amplified by PCR using pRH46 as a 
template and the following primers: 5'-AGT GAA TTC ATA ATG AGT 
GGC AAC TCT GC-3' (nt -3 to  +17, SED4) and 5'-ATG GGT ACC 
GTC GAC CTA GCG  GCC GCT T/T  CCA AAT ATT TCG TAA 
AAT TGA TG-3' (nt 1214-1239, SED4). The amplified fragment was cut 
with EeoRI-KpnI and ligated into pCD43, producing pRH183. A cassette 
encoding three copies of the myc epitope flanked by NotI sites was con- 
structed using overlapping oligonucleotides (kindly provided by B. Fut- 
cher, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY). The oli- 
gonucleotides  were  annealed,  filled  in,  and  ligated  into  Notl-cut 
Bluescript vector (pKS +) to make pRH177/23. The nucleotide sequence 
of the 3Xmyc cassette in pRH177/23  is 5'-GCG GCC GCT CTG AGC 
AAA AGC TCA 111  CTG AAG AGG ACT TGA ATG GAG AAC 
AGA AAT TGA TCA GTG AGG AAG ACC TCA ACG GTG AGC 
AGA AGT TAA TAT CCG AGG AGG ATC TTA ATA GTG CGG 
CCG C-3'. The 3Xmyc cassette of pRH177/23 was ligated into NotI-cut 
pRH183, the resulting product was cut with PvuI and inserted into PvuI- 
cut pRS313, creating pRH260. By DNA sequencing, pRH260 encodes a 
protein with three tandem repeats of the myc epitope plus 14 additional 
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Strain  Genotype  Source or Reference 
CKY8  MATa ura3-52  leu2-3,  112  Kaiser lab collection 
CKY10  MATa ura3-52  leu2-3,  112  Kaiser lab collection 
CKY93  MATa ura3-52  leu2 pep4:URA3  Kaiser lab collection 
CKY289  MATa ura3-52  leu2 his3A200 trp 1A63 lys-801  Gal  ÷  Kaiser lab collection 
CKY249  MATa/MATct SED4/sed4-AI::URA3 ura3-52/ura3-52  This study 
leu2- 3, 112/leu2-3,  112 
CKY250  MATa/MATa SED4/sed4-A1 ura3-52/ura3-52  This study 
leu2- 3  , 112/1eu2-3, 112 
CKY251  MATa sed4-A1 ura3-52  leu2-3,  112  This study 
CKY252  MATa ura3-52  leu2-3,  112  This study 
CKY255  MATa sed4-AI::URA3 ura3-52  leu2-3,  112  This study 
CKY258  MATa sed4- A I :  : URA3 ura3-52  leu2-3,  112  This study 
CKY291  MATa ura3-52  leu2-3,  112  This study 
CKY292  MATa sed4-AI::URA3 ura3-52  leu2-3,  112  This study 
CKY293  MATa sed4-AI::URA3 sarl-5 ura3-52  leu2-3,  112  This study 
CKY294  MATa sarl-5 ura3-52  leu2-3,  112  This study 
CKY295  MATa sed4-A1 ura3-52  leu2-3,  112 pep4::LEU2 (pRH121)  This study 
CKY296  MATa sed4-A1 SARI ::URA3 ura3-52  1eu2-3,112  This study 
CKY39  MATa sec12-4  ura3-52  his4-619  Kaiser lab collection 
CKY45  MATc~ sec13-1  ura3-52  his4-619  Kaiser lab collection 
CKY50  MATa sec16-2  ura3-52  his4-619  Kaiser lab collection 
CKY52  MATa sec16-1  ura3-52  leu2-3,  112  Kaiser lab collection 
CKY54  MATa secl7-1 ura3-52  his4-619  Kaiser lab collection 
CKY58  MATa secl8-1 ura3-52  his4-619  Kaiser lab collection 
CKY62  MATa sec19-1  ura3-52  his4-619  Kaiser lab collection 
CKY64  MATa sec20-1  ura3-52  his4-619  Kaiser lab collection 
CKY69  MATa sec21-1  ura3-52  his4-619  Kaiser lab collection 
CKY70  MATa sec22-3  ura3-52  his4-619  Kaiser lab collection 
CKY78  MATa sec23-1  ura3-52  his 4-619  Kaiser lab collection 
CKY105  MATa sec16-3  ura3-52  leu2-3,  112  Kaiser lab collection 
CKY230  MATa secl6-4 ura3-52  leu2-3,  112 ade2 ade3 sec13-1  Kaiser lab collection 
(pCEN-ADE3-SEC13) 
NY768  MATa secl-1 ura3-52  leu2-3,  112 
NY770  MATa sec2-41  ura3-52  leu2-3,  112 
NY772  MATa sec3-2  ura3-52  leu2-3,  112 
NY774  MATa sec4-8 ura3-52  leu2-3,  112 
NY776  MATa sec5-24 ura3-52  leu2-3,  112 
NY778  MATa sec6-4 ura3-52  leu2-3,  112 
NY780  MATa sec8-9 ura3-52  leu2-3,  112 
NY782  MATa sec 9-4 ura3-52  leu2-3,  112 
NY784  MATa seclO-2 ura3-52  leu2-3,  112 
NY786  MATa sec15-1  ura3-52  leu2-3,  112 
AFY72  MATa sec7-1  ura3-1  his3-11  trpl-1 
ANY123  MATa bet1-1  ura3-52  his4-619 
ANY125  MATa bet2-1  ura3-52  his4-619 
RSY533  MATa sec61-2  ura3-52  leu2-3,  112 ade2 pep4-3 
RSY530  MATa sec62 ura3-52  leu2-3,  112 
RSY153  MATa sec63-1  ura3-52  leu2-3,  112 
CKY234  MATa sec16-Al::TRP1 lys2-801  ade 2-101  trp1-A63 
his3-A200 ura3-52  leu2-A1  (pPE5) 
RSY656  MATa/MATa SEC12/sec12A::LEU2 ura3-1/ura3-1  d'Enfert et al., 1991a 
leu2-3/leu2-3  trpl-1/trpl-1 ade2-1/ade2-1 
his3-11/his3-11  canl-lOO/canl-lO0 
P. Novick (Yale University) 
P. Novick (Yale University) 
P. Novick (Yale University) 
P. Novick (Yale University) 
P. Novick (Yale University) 
P. Novick (Yale University) 
P. Novick (Yale University) 
P. Novick (Yale University) 
P. Novick (Yale University) 
P. Novick (Yale University) 
R. Schekman (U.C. Berkeley) 
S. Ferro-Novick (Yale University) 
S. Ferro-Novick (Yale University) 
R. Schekman (U.C. Berkeley) 
R. Schekman (U.C. Berkeley) 
R. Schekman (U.C. Berkeley) 
Espenshade et al., 1995 
EGY40  MATa ura3-52  leu2 his3 trpl  Golemis and Brent, 1992 
PRY303  MATa dpml ::LEU2 leu2-3,  112 lys2-801  trpl A1 ura3-52  Orlean, 1990 
(pdpml-6) 
amino acids at the COOH terminus. The NH2-terminal domain of SEC12 
was similarly placed under control of the GALIO promoter and tagged 
with the myc epitope. A 1-kb fragment encoding aa 1-354 of SEC12 plus a 
NotI site was amplified by PCR using pSEC1230 as a template and the fol- 
lowing primers: 5'-AGT GAA TTC ACT ATG AAG TTC GTG ACA 
G-3' (nt  -3  to  +16, SEC12)  and 5'-TGC GCT CGA GCT AGC GGC 
CGC TI'I" TAG AGA TIT TIT GTT TCA TFG AGG-3' (nt 1037-1062, 
SEC12).  The amplified fragment was cut with EcoRI-KpnI and ligated 
into  pCD43,  producing pRH186.  The  3×myc cassette was ligated into 
NotI-cut pRH186, the resulting product was cut with PvuI and inserted 
into PvuI-cut pRS313, creating pRH261. By DNA sequencing, pRH261 
encodes a protein with three tandem repeats of the myc epitope plus 14 
additional amino acids at the COOH terminus. 
Construction of a SED4 Deletion Allele 
A  deletion of the entire SED4 open reading frame (sed4-A1)  was con- 
structed by site-directed mutagenesis. The mutagenic oligomer (5'-CTT 
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Plasmid  Description  Source or Reference 
pRS306 
pRS316 
pRS313 
pRS315 
pRS306-2~ 
pRS305-2~ 
pRH46 
pRH 107 
pPE87 
pRH 120 
pRH121 
pRH47 
pRH54 
pRH78 
pRH 128 
pRH62 
pRH141 
pRH 148 
pRH50 
pRH213 
pPE5 
pPE8 
pKR 1 
pCK1313 
YCP1142 
pRH259 
pRH262 
pRH279 
pRH280 
pEG202 
pJG4-5 
pSH 18-34 
pPE58 
pPE59 
pPE74 
pRH151 
pRH152 
pRH260 
pRH261 
pRD56 
pPE122 
integrating vector marked with URA3 
centromere vector marked with URA3 
centromere vector marked with H1S3 
centromere vector marked with LEU2 
2p. vector marked with URA3 (pRS306 derivative) 
2~ vector marked with LEU2 (pRS305 derivative) 
SED4 in pRS306-21x 
SED4 in pRS316 
SED4 in pRS305-21x 
SED4-HA in pRS306-2tx 
SED4-HA in pRS316 
SED4 (1-841) in pRH306-2lx 
SED4 (1-369) in pRS306-2tz 
SED4 (1-343) in pRS306-2~ 
SED4 (1-294/331-1061) in pRS 306-21x 
SEC12 (1-374) fused to SED4 (368-1065) in pRS306-2~ 
SEC12 (1-374) fused to SED4-HA (368-1065) in pRS306-21x 
SEC12 (1-374) fused to SED4-HA (368-1065) in pRS316 
SEC12 in pRS306-21~ 
SEC12 in pRS316 
SEC16 in YCp50 
SEC16 in pRS315 
SEC13 in pRS316 
SEC13 in YEp352 
SEC23 in YCp50 
SAR1 in pRS316 
sarl-5 in pRS316 
sarl-5 in pRS306-21~ 
SAR1 in pRS306-2~ 
lexA DNA binding domain in a 2p. vector marked with HIS3 
acidic activation domain in a 21z vector marked with TRP1 
lacz gene under control of eight lexA DNA binding sites in a 
2~ vector marked with URA3 
SEC16 (1645-2194) in pEG202 
SEC16 (1-824) in pEG202 
SEC16 (447-1737) in pEG202 
SED4 (1-347) in pJG4-5 
SEC12 (1-354) in pJG4-5 
GALlO-promoted SED4-MYC (1-347) in pRH313 
GALlO-promoted SEC12-MYC (1-354) in pRS313 
GALl-promoted GST in pRS316 
GALl-promoted GST-SEC16 (1638-2194) in pRS316 
Sikorski and Hieter, 1989 
Sikorski and Hieter, 1989 
Sikorski and Hieter, 1989 
Sikorski and Hieter, 1989 
Miller and Fink, unpublished data 
Miller and Fink, unpublished data 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Espenshade et al., 1995 
Espenshade et al., 1995 
Roberg and Kaiser, unpublished data 
Pryer et al., 1993 
Hicke and Schekman, 1989 
This study 
This study 
This study 
This study 
Gyuris et al., 1993 
Gyuris et al., 1993 
Gyuris et al., 1993 
Espenshade et al., 1995 
Espenshade et al., 1995 
Espenshade et al., 1995 
This study 
This study 
This study 
This study 
R. Deshaies (California Institute of 
Technology) 
This study 
Numbers in parentheses  indicate  the amino  acid numbers  of the preceding  gene's product. 
TTA AAC TTA GAA AAA CTA GCA TAA TAA TGG ATC CAA 
GCT TGA ATA ACG AAA TAA TAT ATA TTA ATG TTA AAT 
ATG-3') consisted of 32 nucleotides  complementary  to the 3' untrans- 
lated region of SED4, 10 nucleotides creating a HindIII and a BamHI site 
(underlined), and 36 nucleotides complementary to the 5' untranslated  re- 
gion of SED4.  Mutagenesis of pRH67  deleted the entire SED4 reading 
frame as shown by restriction  mapping.  A  5-kb marker cassette  (hisG- 
URA3-Kanr-hisG) (modification of Alani et al., 1987; kindly provided by 
S. Elledge, Baylor College of Medicine, Houston,  TX) was inserted into 
the newly created BamHI site to make pRH73 (sed4-AI::URA3). 
A diploid (CKY8 ×  CKY10) was transformed with a 6.9-kb, purified 
SacI-SalI fragment of pRH73. Tetrad analysis of Ura  + transformants gave 
2:2 segregation  of URA3.  By Southern  blot analysis, the genomic SED4 
locus  was deleted in  four  Ura  + spores examined.  Loss  of the  URA3 
marker by recombination  of the hisG repeats was selected on SC medium 
containing 0.1% 5-fluoroorotic acid to produce sed4-A1. 
Protein Extracts, Western Blotting, 
and Cell Fractionation 
Yeast protein extracts were prepared from 2--6 x  107 exponentially grow- 
ing cells as described (Rothblatt and Schekman, 1989). Cells were lysed in 
30 ixl ESB (60 mM Tris HC1, pH 6.8, 100 mM DTT, 2% SDS, 10% glyc- 
erol, 0.001% bromphenol blue)  by vigorous agitation  with 0.5-mm glass 
beads (Sigma Chemical Co., St. Louis, MO). Extracts were diluted with 70 
~.l of ESB and 10-20 tJ.1 were resolved by SDS-PAGE (Laemmli, 1970). 
Western blotting  was performed using standard methods (Harlow  and 
Lane,  1988). The  following  antibodies  were  used:  anti-HA  antibody 
(12CA5 ascitic fluid; BAbCO, Richmond,  CA) at 1:1,000 dilution,  anti- 
myc antibody (9E10 ascitic fluid; K. Morrison, Harvard University, Boston, 
MA) at 1:1,000 dilution, rabbit anti-carboxy peptidase Y (CPY) antibody 
(gift of R. Schekman) at 1:5,000 dilution, HRP-coupled sheep anti-rabbit 
Ig (Amersham Corp.) at 1:10,000 dilution and HRP-coupled sheep anti- 
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oped using the ECL system (Amersham Corp.).  Cell fractionation was 
performed as described (Espenshade et al., 1995) using CKY295. 
Radiolabeling and Immunoprecipitations 
Ceils were grown in selective SC medium supplemented with 2% glucose 
and then shifted to the indicated temperatures 2 h before labeling. Tunica- 
mycin treatment and temperature-shift experiments of the dpml-6 mutant 
were performed as described (Orlean et al., 1991).  2-6  x  107 exponen- 
tially growing cells (1-3 OD600 U) were radiolabeled in supplemented SD 
medium by incubating with 30 p.Ci [3SS]methionine per OD600 U (Express 
protein labeling mix; New England Nuclear, Boston, MA), sp act 1,200 Ci/ 
mmol). Samples were chased by the addition of 1:100  vol of a  solution 
containing 0.1 M ammonium sulfate, 0.3% cysteine, 0.4% methionine. La- 
beled samples of 1 OD600 U of cells were collected into chilled tubes con- 
taining an equal volume of 40 mM sodium azide. Protein extracts were 
prepared in 30  i~l ESB by vigorous agitation with glass beads. Extracts 
were diluted with 1 ml IP buffer (50 mM Tris HC1, pH 7.4, 150 mM NaCI, 
1% Triton X-100, 0.2% SDS), absorbed for 20 min with 50 p,l 10% Staphy- 
lococcus aureus cells (Sigma Chemical Co.) and cleared by centrifugation 
at 12,000 g for 5 rain. 0.5 ~1 anti-CPY or anti-HA antibody was added and 
extracts were rotated for 1 h  at 25°C. Immune complexes were collected 
by adding 30 p.l 50% protein A-Sepharose (Pharmacia LKB Biotechnol- 
ogy, Inc., Piscataway, N J) per sample and incubating for 1 h at 25°C. Pro- 
tein A-Sepharose beads were washed twice with IP buffer and once with 
detergent-free IP buffer (50 mM Tris HC1, pH 7.4, 150 mM NaC1). Protein 
was released into 30 ixl ESB by heating to 100°C for 2 min. 10 ixl superna- 
tant was separated by SDS-PAGE,  visualized by fluorography (Harlow 
and Lane, 1988),  and imaged on a phosphorlmager (Molecular Dynamics, 
Sunnyvale, CA). 
Two-Hybrid Protein-Protein Interaction Assay 
Sed4p and Sec12p were tested for binding to Sec16p in vivo as described 
by Gyuris et al., 1993. The NH2-terminal domain of Sed4p or Sec12p was 
fused to the acidic activation domain in pJG4-5 as follows. A fragment en- 
coding aa 1-347 of SED4 was amplified by PCR using pRH46 as a tem- 
plate and the following primers: 5'-AGT GAA T£C ATA ATG AGT 
GGC AAC TCT GC-3' (nt  -3 to +17, SED4) and 5'-CTA GTC GAC 
CTA TIT CCA AAT ATT TCG TAA AAT TGA TG-3' (nt 1038-1016, 
SED4). The corresponding fragment encoding aa 1-354 of SEC12 was am- 
plified similarly using pSEC1230 as a template and the following primers: 
5'-AGT GAA TTC ATG AAG TTC GTG ACA GCT AG-3' (nt 1-20, 
SEC12)  and 5'-TGC GCT CGA GCT ATT TAG AGA TIT l'l'l' GTT 
TCA TI'G  AGG-3'  (nt  1062-1037,  SEC12).  Fragments were  cut with 
EcoRI-SalI  (SED4) or EcoRI-XhoI  (SEC12)  and ligated into  EcoRI- 
XhoI-cut pJG4-5 to make pRH154 and pRH155, respectively, pPE58, 59, 
and 74 are plasmids encoding aa 1645-2194, aa 1-824, and aa 447-1737 of 
SEC16 fused to the lexA DNA-binding domain in pEG202 (Espenshade 
et al., 1995). 
Two-hybrid interactions were tested in EGY40  (Golemis and Brent, 
1992)  transformed with the appropriate  plasmids. LacZ expression was 
tested by patching four to eight transformants on SC medium (pH 7.0) 
lacking the appropriate amino acids and supplemented with 2% galactose 
and 40 mg/liter X-gal. For p-galactosidase assay, cells were grown to expo- 
nential phase in selective medium containing 2% raffinose, then galactose 
was added to 2% and growth was continued for 10 h. Extracts were pre- 
pared and assayed as described (Kaiser et al., 1994).  Protein concentra- 
tions in the extracts were determined using the Bradford assay (Bio-Rad 
Laboratories,  Melville, NY).  Units of [3-galactosidase are expressed as: 
[OD420 X vol of assay]/[0.0045 x  protein concentration in extract ×  vol of 
extract assayed x  time]. 
Binding to GST Fusions 
The COOH terminus of Sec16p (amino acids [aa] 1638-2194) was fused to 
the glutathione-S-transferase gene (GST) expressed from the GALl pro- 
moter (pRD56,  a  kind gift of Dr.  Ray Deshaies, California Institute of 
Technology, Pasadena,  CA)  to  create  pPE122.  The  NH2-terminal do- 
mains of Sed4p and Sec12p were expressed from the GALIO promoter 
and  tagged  with  the  myc  epitope  as  described  above  (pRH260  and 
pRH261), pPE122 and either pRH260 or pRH261 were transformed into 
CKY289. For controls, CKY289 carrying pRD56 and either pRH260 or 
pRH261 were used. 
Cells were grown to exponential phase in selective medium containing 
2% raffinose, galactose was added to 2%, and extracts were prepared 4 h 
later. 4  x  107 cells were suspended in 40 ILl ColP buffer (20 mM Hepes, 
pH 6.8, 80 mM potassium acetate, 5 mM magnesium acetate, 0.1% Triton 
X-100) containing 2.5  x  10  -4 U/ml ct2-macroglobulin, 1 mM PMSF, 0.5 
p,g/ml leupeptin, 10 p.g/ml E64, and 0.4 p,g/ml  aprotinin (all Boehringer 
Mannheim Biochemicals, Indianapolis, IN)  and were lysed by vigorous 
agitation with 0.5 mm glass beads 4 x  20 s with 1-min intervals on ice. Ex- 
tracts were diluted to 1 ml with ColP buffer with protease inhibitors, and 
the lysate was cleared by centrifugation at 13,000 g for 5 min. Glutathione 
Sepharose 4B beads (Pharmacia LKB Biotechnology, Inc.) were added 
and samples were incubated for 1 h at 25°C. The beads were washed three 
times with ColP buffer and once with detergent-free ColP buffer. Proteins 
were released from the beads by boiling in 30 ILl ESB. Total protein ex- 
tracts were prepared from 2  x  107 cells lysed in ESB by agitation with 
glass beads. 
Immunofluorescence 
Indirect immunofluorescence was performed essentially as described by 
Pringle et al., 1991.  Cells were fixed by adding formaldehyde (final con- 
centration of 3.7%) to the medium and incubating for 2 h at 25°C. Fixed 
cells suspended in  0.1  M  potassium phosphate  (pH  7.2)  were  sphero- 
plasted with 50 U  lyticase for 30 min at 37°C.  Incubations in primary or 
secondary antibody were for 1 h and were performed in a humid chamber 
at 25°C. The antibodies and concentrations used were: 12CA5 at a 1:5,000 
dilution, anti-BiP polyclonal antiserum (kind gift of M. Rose, Princeton 
University, NJ)  at  1:1,000  dilution, FITC-coupled goat anti-rabbit  IgG 
and rhodamine-coupled goat anti-mouse IgG  (both  Boehringer Mann- 
heim Biochemicals) at 1:300 dilution. Cells were mounted in medium con- 
taining  4,6-diamidino-2-phenylindole  and p-phenylenediamine.  Images 
were recorded on an axioscope (Carl Zeiss, Thornwood, NY) using film 
(T-Max 400; Eastman Kodak Co., Rochester, NY) developed according to 
the manufacturer's specifications. 
Electron Microscopy 
Electron microscopy was performed as described in Kaiser and Schek- 
man, 1990.  Wild-type (CKY291), sed4-A1 sarl-5 (CKY293), and secl7-1 
(CKY54)  cells were  grown to  exponential phase in YPD  at  24°C and 
shifted to 38°C for 2 h  before fixation. Cells were fixed for electron mi- 
croscopy with potassium permanganate. To count vesicles, random well- 
stained sections were selected, photographed at a magnification of 13,000, 
and vesicles seen on the negative were counted. Vesicle counts were nor- 
malized to cell volume by measuring the area of the cell section and as- 
suming a section thickness of 90 nm. 29 and 33 cell sections were counted 
for the sed4-A1 sarl-5 and the secl7-1  strain, respectively. Data are ex- 
pressed as mean _+ SEM. 
In Vitro Vesicle Synthesis 
Membranes and cytosol used in the vesicle synthesis reaction were pre- 
pared as previously described (Wuestehube and Schekman, 1992)  using 
CKY295 as a  source of membranes and CKY93 as a  source of cytosol. 
Standard vesicle synthesis reactions of 500 txl contained 100  txg of mem- 
branes, 1.2 mg of cytosol prepared in the absence of added guanine nucle- 
otide, 1 mM GDP-mannose, 0.1 mM guanine nucleotide, and an ATP re- 
generation system in reaction buffer (20 mM Hepes-KOH pH 6.8, 150 mM 
KOAc, 5 mM MgOAc, 250 mM sorbitol) with protease inhibitors (1 mM 
PMSF, 0.5 ng/p,1 leupeptin, 1 I.LM pepstatin). The reaction with apyrase 
added contained 10 U/ml of apyrase in the place of the ATP regeneration 
system. Reactions were incubated at 20°C for 2 h. Donor membranes were 
removed by centrifugation at 32,000 rpm for  10 min at 4°C in a  rotor 
(TLA100.3; Beckman Instruments, Inc., Fullerton,  CA).  Vesicles were 
pelleted from this medium speed supernatant by centrifugation at 60,000 
rpm for 30 min at 4°C in a TLA100.3 rotor. Vesicle pellets were solubi- 
lized in 30 ILl ESB and proteins were analyzed by Western blotting. 
Vesicles formed in vitro were fractionated by gel filtration on a  14 ml 
(18 cm) Sephacryl S-1000 column (Sigma Chemical Co.) equilibrated in 
reaction buffer as described (Barlowe et al., 1994). A 0.7-ml sample of me- 
dium speed supernatant from two 0.5-ml reactions was applied to the col- 
umn, eluted in reaction buffer, and 0.75-ml fractions were collected. Vesi- 
cles in each fraction were concentrated by centrifugation at 60,000 rpm for 
30 min at 4°C in a TLA100.3 rotor. Proteins solubilized in 30 ~l ESB were 
analyzed by Western blotting. 
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sarl-5 was cloned by gap repair as follows: pRH259 contains the SAR1 
gene on a 1.3-kb  HindIII-SalI  fragment of pSEC1210 (Nakano and Mura- 
matsu, 1989) inserted into pRS316 with a deletion from the EcoRI to the 
NotI sites of the polylinker. A sarl-5 sed4-A1 double mutant was trans- 
formed with plasmid pRH259 cut with EcoRI and BamHI to produce a 
gap covering the SAR1 coding sequence. Gap-repaired plasmids carrying 
the mutation (pRH262) were identified by their inability to suppress the 
temperature  sensitivity of secl6-2 and sec23-1 strains. The  mutational 
change in a plasmid carrying sarl-5 was identified by sequencing with syn- 
thetic oligonucleotide primers. SAR1 and sarl-5  were placed on a 2~. plas- 
mid  by inserting  the  1-kb EcoRI-HindIII fragment  of pRH259 and 
pRH262 into pRS306-2~, creating pRH280 and pRH279. 
Results 
SED4 Is a Multicopy Suppressor of sec  l 6 Mutations 
secl6-2  mutants fail to grow at temperatures above 30°C 
(Fig.  1,  column  1).  To  identify genes  that  interact  with 
SEC16, we screened a S.  cerevisiae genomic DNA  library 
in  a  multicopy  (2~)  vector  for  plasmids  that  permit  Ts 
secl6 mutants to grow at restrictive temperatures. One set 
of overlapping plasmids was recovered that suppressed the 
growth defect of secl6-2 cells up to 36°C (Fig. 1, column 2). 
Subcloning and sequencing identified the suppressing lo- 
cus as SED4. 
SED4 overexpression partially suppressed the Ts growth 
defect  of  all  four  secl6  alleles  (not  shown).  However, 
SED4 overexpression could not bypass a secl6 null allele 
(secl6-AI::TRP1)  as demonstrated  in  the  following plas- 
mid shuffling experiment. CKY234 carries a chromosomal 
secl6-AI::TRP1  allele and a  URA3-marked  plasmid con- 
taining SEC16.  CKY234 transformed with SED4 on a  2ix, 
LEU2-marked  plasmid  (pPE87)  could not  grow without 
the  URA3-marked  SEC16  plasmid,  whereas  CKY234 
transformed  with  SEC16  on  a  LEU2-marked  plasmid 
(pPE8) could grow without the URA3-marked plasmid. 
We  examined  the  ability of  SED4  overexpression  to 
suppress  Ts  mutations  in  other  secretion genes.  The sec 
and bet mutants listed in Table I were transformed with ei- 
ther SED4 on a multicopy plasmid (pRH46) or the 2Ix vec- 
tor  alone, and  tested for growth  at 30, 33,  36,  and 38°C. 
Overexpression of SED4 partially suppressed the growth 
defect of sec2-41 at 33°C, but had no effect on the growth 
defect  of  any  of  the  other  mutants  tested.  Importantly, 
overexpression of SED4 did not suppress the growth de- 
fect  of a  strain carrying a  mutation  in SEC12,  the  gene 
most like SED4. 
The ability of SED4 overexpression to suppress the se- 
cretion  defect  of sec16-2  was  examined  by following the 
maturation of the vacuolar enzyme CPY. Covalent modifi- 
cations of CPY in the ER, the Golgi complex, and the vac- 
uole  mark  the  early  events  in  the  secretory  pathway 
(Stevens et al., 1982).  Strains were grown at 32°C for 2  h, 
labeled for  5  min,  and  then  chased.  In  a  sec16-2  strain, 
none of the ER form (pl) of CPY was converted into the 
mature, vacuolar form (m) even after 30 min (Fig. 2, lanes 
1-5),  whereas the  same  strain containing SED4  on  a  2ix 
plasmid allowed maturation of CPY  (Fig. 2, lanes 6-10). 
Thus, the suppression of the secretion defect of sec16-2 by 
SED4 parallels the suppression of the growth defect. 
Conserved NH2-terminal and Transmembrane 
Domains of Sed4p Confer Suppression of the Growth 
Defect of secl6-2 Strains 
To identify the portion of SED4 required for suppression 
of secl6, truncations of SED4 were tested. In comparison 
to SEC12,  SED4  is comprised of an  NH2-terminal cyto- 
solic domain, a transmembrane domain, and a COOH-ter- 
minal luminal domain. SED4 alleles with either a  partial 
(sed4-T1) or a complete (sed4-T2) deletion of the COOH- 
terminal domain suppressed secl6-2 almost as well as wild- 
type  SED4,  demonstrating  that  this  domain  is  not  nec- 
essary  for  suppression  (Fig.  3).  The  NHE-terminal  and 
transmembrane  domains of Sed4p were  required for  sup- 
pression, since deletion of a 39-amino acid segment of the 
NHE-terminal domain (sed4-T4)  or deletion of the  trans- 
membrane  domain  (sed4-T3)  completely  abolished  the 
ability to  suppress secl6-2  (Fig. 3).  To  demonstrate  that 
sed4-T4  is  expressed  at  levels similar to SED4,  we  con- 
structed an  epitope-tagged allele, sed4-T4-HA,  that  con- 
tains the  HA  epitope at  the  same position as SED4-HA 
(see below). By Western blotting, the  levels of Sed4-T4- 
HAp were identical to Sed4-HAp (not shown). 
The function of the COOH-terminal luminal domain of 
Sed4p was further examined by fusing it to the NH2-termi- 
nal and transmembrane domains of Sec12p and testing this 
chimera for suppression of either secl6-2 or secl2-4.  The 
chimera behaved like wild-type SEC12:SEC12-SED4  on 
either a low or a high copy plasmid did not suppress secl6-2, 
but complemented both secl2-4 and a  chromosomal dele- 
tion of secl2  (Fig. 3,  and  data not shown).  These results 
Figure 1.  SED4  overexpres- 
sion suppresses the tempera- 
ture  sensitivity  of  sec16-2. 
Lanes  1  and  2:  A  sec16-2 
strain  (CKY50)  containing 
vector (pRS306-21~) or SED4 
on  a  2ix  plasmid  (pRH46). 
Lanes  3  and  4:  a  wild-type 
strain  (CKY8)  containing 
vector (pRS306-21~) or SED4 
on  a  2~  plasmid  (pRH46). 
Cells were spotted on selec- 
tive  medium  and  incubated 
at the indicated temperatures 
for 40 h. 
Figure 2.  SED4 overexpression suppresses the temperature-sen- 
sitive ER to Golgi transport defect of sec16-2. Lanes 1-5: a secl6-2 
strain  (CKY50)  carrying  vector  (pRS306-2p~).  Lanes  6-10:  a 
sec16-2 strain carrying SED4 on  a  2Ix plasmid (pRH46).  Cells 
were grown in selective medium at 25°C, shifted to 32°C for 2 h, 
and pulse-labeled with [35S]methionine  for 5 min. The label was 
chased  for  the  times indicated.  CPY  was  immunoprecipitated 
from extracts, resolved by SDS-PAGE, and imaged on a  phos- 
phorlmager. 
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domain  of  SED4  is  neces- 
sary  and  sufficient  for  sup- 
pression of secl6-2. The indi- 
cated  2~  plasmids  were 
transformed  into  CKY50 
(sec16-2),  CKY251  (sed4- 
A1),  CKY39  (sec12-4),  and 
RSY656  (SEC12/sec12A). 
Growth of single colonies as- 
sayed on selective  medium at 
33°C (sec16-2, sec12-4) or on 
rich  medium  at  41°C  (sed4- 
A1) is shown. + + +  indicates 
growth comparable to wild type, -  indicates no growth. Complementation/suppression of sec12-4 and sec16-2 strains was also tested at 
30  ° and 36°C with similar results.  Suppression of secl2A was assayed by sporulating heterozygous sec12A diploids carrying test plasmids, 
dissecting  10-20 tetrads, and scoring Leu  ÷ (sec12A) spores.  + + +  indicates that Leu  ÷ spores were readily obtained, -  indicates that no 
Leu  ÷ spores were obtained. 
demonstrate  that the function of SED4 is specified by its 
conserved NHa-terminal and transmembrane domains. 
Sed4p Is an O-glycosylated ER Membrane Protein 
Sed4p was epitope tagged by inserting seven copies of the 
HA epitope before the COOH-terminal HDEL sequence 
(see  Materials  and  Methods).  Epitope-tagged  SED4  ap- 
peared to be functional since SED4-HA suppressed secl6-2 
to the same extent as untagged SED4 (not shown). Immu- 
noblots  probed  with  anti-HA  antibodies  detected  a  pro- 
tein  that  migrated  more slowly than  a  190-kD molecular 
mass standard  (Fig. 4 A, lane 1).  As expected for Sed4p- 
HA, this band was more abundant in a strain overexpress- 
ing Sed4p-HA (Fig. 4 A, lane 2) and was not present in a 
strain expressing untagged SED4 (Fig. 4 A, lane 5). 
An epitope-tagged  Secl2-Sed4p  fusion protein  (Fig. 3) 
was useful for estimating the abundance of Secl2p relative 
to  Sed4p.  Since  both  Sed4p-HA  and  the  chimera  were 
tagged  at  the  same  position  and  migrated  similarly  on 
SDS-PAGE, they were likely to be detected with equal ef- 
ficiency by Western  blotting.  Sed4p-HA expressed  from 
either  a  high  or a  low copy vector was 5-10 times  more 
abundant than Sec12-Sed4p-HA, expressed from the same 
vector (Fig. 4 A, compare lanes I  and 3 and lanes 2 and 4). 
The difference between the observed molecular mass of 
Sed4p-HA (>190 kD)  and the molecular mass predicted 
from the  amino  acid sequence  (117  kD)  prompted  us to 
examine possible modifications of Sed4p. The COOH-ter- 
minal,  luminal  domain of Sed4p  contains  three  potential 
N-linked glycosylation sites and is rich in serine and threo- 
nine  residues  that  could  accept  O-linked  glycosylation. 
Unglycosylated  Sed4p-HA  was  produced  in  PRY303,  a 
strain that carries a Ts mutation in dolichol phosphoman- 
nose synthase, an enzyme required for both N- and O-linked 
glycosylation (Orlean,  1990).  Sed4p-HA, immunoprecipi- 
tated from PRY303 cells labeled at the restrictive temper- 
ature, migrated more rapidly than Sed4p-HA expressed in 
wild-type cells (Fig. 4 B, lane 4), indicating that Sed4p-HA 
is a glycoprotein. Treatment  of cells with tunicamycin, an 
inhibitor  of N-linked  glycosylation,  or  treatment  of  ex- 
tracts  with  Endo  H  to  remove  N-linked  carbohydrate 
chains  had  no  effect  on  the  electrophoretic  mobility  of 
Sed4p-HA (Fig. 4 B, lane 5; and data not shown), indicat- 
ing that Sed4p-HA is modified primarily by O-glycosyla- 
tion. The discrepancy between the migration of Sed4p-HA 
without  carbohydrate  modifications  (190  kD)  with  that 
predicted from the amino acid sequence (117 kD) is prob- 
ably  due  to  anomalous  migration  on  SDS-PAGE  since 
Sed4p-HA expressed in bacterial cells also migrated at 190 
kD (not shown). 
Figure 4.  (A) Immunodetection of Sed4p-HA and comparison of 
the protein levels of Sed4p-HA and Secl2-Sed4p-HA fusion pro- 
teins.  The SEC12-SED4  fusion construct is described in Fig.  3. 
Wild-type cells (CKY10) carrying the indicated plasmids (pRH121, 
pRH120, pRH148, pRH141, and pRH46; lanes 1-5, respectively) 
were grown in selective  medium. Extracts of 0.2 ODr00 U of cells 
were resolved by SDS-PAGE on 6% gels and HA-tagged proteins 
were detected by Western blotting. (B) Sed4p-HA is an O-glyco- 
sylated  protein.  Sed4p-HA  was  immunoprecipitated  from  ex- 
tracts from either wild-type (CKY10) (lanes 1,2, and 5) or dpml-6 
(PRY303)  (lanes 3  and 4)  strains  carrying SED4-HA  on a  21~ 
plasmid (pRH120). Cells were grown in minimal medium, shifted 
to the indicated temperatures for 15 min, and radiolabeled with 
[35S]methionine for 15 min. Tunicamycin was added to 10 p,g/ml 5 
min before labeling (lane 5). HA-tagged proteins were immuno- 
precipitated from extracts from 10D600 U  of cells  and labeled 
proteins were visualized  by fluorography after SDS-PAGE on a 
6% gel. 
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fractionation. A  large fraction of Sed4p-HA in a cell lysate 
pelleted at 500 g  and the  remainder pelleted at 10,000  g 
(not shown). As expected for an integral membrane pro- 
tein, Sed4p-HA was partially solubilized from the 10,000-g 
pellet by treatment with 1% Triton-X 100, but was not re- 
leased by treatment with 2.5  M  urea, 0.5  M  NaC1, or so- 
dium carbonate (pH 11) (not shown). 
The intracellular  location of Sed4p-HA was examined 
further by indirect immunofluorescence. Fig. 5 (top) shows 
diploid cells expressing SED4-HA from a high copy plas- 
mid  stained  with  anti-HA  antibody.  The  staining  was 
chiefly at the  nuclear periphery with extensions  into the 
cytoplasm and around the periphery of the cell body. This 
pattern is typical for proteins located in the ER (Rose et 
al.,  1989).  The  anti-HA staining pattern was identical  to 
the anti-BiP staining observed in a double-labeling experi- 
ment (Fig. 5, bottom), indicating that Sed4p-HA is distrib- 
uted throughout the ER. A  similar, though weaker, stain- 
ing  was seen  for Sed4p-HA  expressed  from a  low copy 
plasmid, while no staining was apparent in a control strain 
transformed with untagged SED4 (not shown). 
Sed4p Is Excluded from ER Vesicles Produced In Vitro 
To investigate whether Sed4p is present on vesicles that 
have budded from the ER, we followed the fate of Sed4p- 
HA in a cell-free ER budding reaction (Wuestehube and 
Schekman,  1992).  ER  membranes were  isolated  from  a 
sed4 deletion strain expressing Sed4p-HA from a low copy 
plasmid. Vesicles were produced by incubating these mem- 
branes with a guanine nucleotide and cytosol. Vesicles that 
had formed in vitro were isolated by first removing the do- 
nor  membranes by centrifugation  at  medium speed  and 
then pelleting the vesicles at high speed. Sec22p was used 
as a vesicle marker protein and N10%  of Sec22p was re- 
covered in the high speed pellet (HSP) after incubation of 
donor membranes at 20°C with GTP and cytosol (Fig. 6). 
Incubation at 4°C, in the presence of apyrase, or in the ab- 
sence  of cytosol decreased the  amount  of Sec22p  in  the 
HSP by 10-fold, while incubation in the presence of GMP- 
PNP,  a  nonhydrolyzable  GTP analogue,  reduced  vesicle 
formation by about twofold. The conditions that promote 
vesicle formation in these reactions, and the efficiency of 
vesicle formation are  consistent  with  those  found previ- 
ously (Rexach et al.,  1994).  Sed4p-HA was detectable in 
both  ER  membrane  and  vesicle fractions,  but  only 0.1- 
0.5%  of membrane-bound  Sed4p-HA  was  released  into 
the vesicle fraction at 20°C as compared with 10%  of the 
input Sec22p. Even less (0.01%) was released on incuba- 
tion  at 4°C,  without  GTP or with  GMP-PNP.  To deter- 
mine whether the small amount of Sed4p-HA released in a 
GMP-PNP reaction was present on ER to Golgi transport 
vesicles or was associated with another type of membrane, 
the vesicle fraction from a  GMP-PNP reaction was frac- 
tionated  further  by  gel-filtration  chromatography  (Bar- 
lowe et al.,  1994).  Most Sed4p-HA eluted  before Sec22p 
on a Sephacryl S-1000 column (data not shown). Thus, the 
small amount of Sed4p that is released from the ER is not 
in transport vesicles and Sed4p, like Sec12p, appears to be 
largely excluded from budded vesicles. 
Figure 5.  Sed4p-HA is located  in the ER. Indirect immunofluo- 
rescence of a wild-type diploid strain (CKY8 × CKY10) carrying 
SED4-HA on a 21~ plasmid (pRH120). Fixed cells were incubated 
with  both anti-HA and anti-BiP  antibodies.  The anti-HA anti- 
body was visualized with rhodamine-coupled secondary antibody 
(top), the anti-BiP  antibody was visualized  with  FITC-coupled 
secondary antibody (bottom). 
NH2-terminal Domain of Sed4p Binds to the 
COOH-terminal Domain of Sec  l 6p 
The  genetic interaction  between  SED4  and  SEC16 sug- 
gested that  their products might physically associate.  As 
an initial test of this possibility we used the two-hybrid sys- 
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Figure 6.  Sed4p-HA is not in- 
corporated  into  ER-derived 
vesicles.  Vesicles  were  pro- 
duced in vitro using ER mem- 
branes from a sed4-A1 strain 
containing  SED4-HA  on  a 
low copy plasmid  (CKY295) 
(see Materials  and Methods). 
The amount of Sed4p-HA or 
Sec22p in the starting mem- 
branes or the vesicle-contain- 
ing HSP was determined by 
Western blotting  and quanti- 
tated  by  densitometry.  The 
ratio of protein in the HSP to protein in the starting membranes 
is expressed as percent release. II, Sec22p; [], Sed4p. 
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terminal domain of SED4 was fused to an acidic transcrip- 
tion activation domain and tested for interaction with each 
of three  overlapping  parts  of SEC16  fused  to  the  lexA 
DNA-binding domain. Interaction was scored by the abil- 
ity of the lexA DNA-binding domain and the acidic activa- 
tion domain to be brought together to drive transcription 
of a lacZ reporter gene. A  strong interaction was detected 
for the combination of the NH2-terminal domain of SED4 
and  the  COOH-terminal  domain  of SEC16  (Table  III). 
This interaction was specific for SED4 since a parallel test 
of the NH2-terminal domain of SEC12 gave no interaction 
(Table III). The possibility that SEC12  failed to interact 
because of poor expression was tested by evaluating pro- 
tein levels by Western blotting with antibodies against the 
HA  tag  present  in  the  acidic  activation  domain.  Both 
Sec12p  and  the  Sed4p  fusion  proteins  were  present  at 
comparable levels, indicating  that the  results of the  two- 
hybrid  test  do  reflect the  inability  of Sec12p  to  interact 
with Sec16p. 
Sed4p and Sec16p were also tested for binding in cell ex- 
tracts. Since Sec16p  (Espenshade  et al., 1995)  and Sed4p 
are both insoluble, we tested association of only the puta- 
tive  interacting  regions  expressed  in  soluble  form.  The 
NH2-terminal domains of Sed4p and Sec12p were tagged 
with the myc epitope and expressed from the GALIO pro- 
moter (SEC12N-MYC and SED4N-MYC). These epitope- 
tagged constructs were first tested for functionality as fol- 
lows. We found that overexpression of either the Sec12p 
NH2-terminal domain or the Sed4p NHE-terminal domain 
has a  dominant negative effect and exacerbates the tem- 
perature sensitivity of secl2-4 and other mutants defective 
in vesicle formation (d'Enfert et al., 1991a;  Gimeno, R. E., 
and  C.  A.  Kaiser,  unpublished  observations).  SEC12N- 
MYC  and  SED4N-MYC  both  inhibited  the  growth  of 
secl2-4 to the same extent as untagged controls, indicating 
that addition of the epitope did not interfere with function. 
These  tagged  domains  were  tested  for  binding  to  the 
COOH-terminal domain of Sec16p fused to GST and ex- 
pressed from the GALl promoter (GST-SEC16C). GST- 
Sec16Cp and associated proteins were isolated by affinity 
to  glutathione  beads  from extracts  prepared  from yeast 
cells expressing GST-SEC16C and either SED4N-MYC or 
Table Ill. NH2-terminal Domain of Sed4p and the 
COOH-terminal Domain of Sec  l 6p Interact in the Two-Hybrid 
Assay 
lexA DNA-binding 
domain  Activation domain 
fl-galactosidase activity 
SED4N  SEC12N  No fusion 
SEC16C  681.6 -  77.2  21.6 -+ 0.3  18.9 -+ 0.1 
SEC16N  18.6 -+ 0.9  15.7 -+ 2.8  16.1  -  2.1 
SEC16CEN  18.2 -+ 2.0  17.2 -+ 0.0  22.5  -+  1.1 
No fusion  100.3 ~  4.5  146.3 _  65.4  74.1  -+ 7.2 
Interactions  were assayed for two independent  transformants  as described  in Materi- 
als  and  Methods.  The values given are means -+  SD.  Plasmids  used  were pPE58 
(SECI6C), pPE59 (SEC16N), pPE74 (SECI6CEN), pRH151  (SED4N), and pRH152 
(SECI2N). 
SEC12N-MYC. Sed4Np-Myc, but not Sec12Np-Myc, asso- 
ciated with GST-Secl6Cp bound to glutathione  beads as 
detected by Western blotting using the anti-myc antibody 
(Fig. 7, lanes I  and 2). The binding of Sed4Np-Myc was de- 
pendent on the presence of Secl6Cp since none associated 
with GST alone (Fig. 7, lanes 3  and 4). Thus, the binding 
experiments gave the same result as the two-hybrid tests: 
Sed4p  can  bind  to  the  COOH-terminal  domain  Secl6p 
and a parallel interaction is not seen for Secl2p. 
Deletion of SED4 Slows Transport of CPY  from the ER 
to the Golgi Complex 
The genetic and physical interactions between Sed4p and 
Sec16p prompted us to examine more carefully the pheno- 
types of a chromosomal deletion of SED4 (sed4-zal). Pre- 
viously,  no  growth  or  secretion  defect  was  found  in  a 
SED4 disruption strain (Hardwick et al., 1992).  Consistent 
with these data, sed4-A1 cells grew as well as isogenic wild- 
type cells at a range of different temperatures (15, 25, 38, 
or 40°C) and showed no accumulation of the ER form of 
CPY by Western blotting (not shown). However, sed4-A1 
strains  did  not  grow  at  41°C,  although  wild-type  strains 
grew  slowly  at  this  temperature.  This  growth  defect  of 
sed4-A1 strains was complemented by SED4 and could be 
suppressed by SAR1, SEC16, or SEC23 on a low copy vec- 
tor,  but  not  by SEC13  or SEC12  (not  shown).  Comple- 
mentation  of sed4-A1  at  41°C  provided  another  test  of 
SED4 function and was also used to establish the impor- 
tance of the NH2-terminal domain (Fig. 3). 
We examined the kinetics of secretion of CPY in sed4- 
A1 cells at 38°C (Fig. 8). In wild-type, 50% of the ER (pl) 
form of CPY was converted to the Golgi (p2) form after 4 
min of chase, and  CPY was completely converted to the 
mature vacuolar (m) form after 8 to 10 min of chase (Fig. 8 
A, lanes  7-12).  In sed4-A1, pl  CPY persisted beyond 10 
min of chase indicating slowed transport from the ER (Fig. 
8 A, lanes 1-6). Quantitation  of the rate of conversion of 
pl  CPY to mature form (Fig.  8 B)  gave a  half-life of pl 
CPY of 7.1 min in a sed4-A1 strain compared with 4.4 min 
in  wild-type  cells.  This  transport  defect  in  sed4-A1, al- 
though subtle, was highly reproducible, and a 1.6- to 2-fold 
lower transport rate from the ER to the Golgi of sed4-A1 
cells was found in four independent experiments. 
Deletion of SED4 Exacerbates Vesicle 
Formation Mutations 
Synthetic lethal interactions between genes that affect the 
Figure  7.  The  NH2-terminal 
domain  of  Sed4p  and  the 
COOH-terminal  domain  of 
Sec16p bind  in extracts.  The 
COOH-terminal  domain  of 
Sec16p  fused  to  GST 
(pPE122,  lanes 1  and 2)  or 
GST only (pRD56, lanes 3 and 4) were expressed in yeast strain 
CKY289 together with either myc-tagged NHE-terminal domain 
of Sed4p  (pRH260,  top  row)  or myc-tagged  NH2-terminal  do- 
main of Sec12p (pRH261, bottom row). Tagged proteins were de- 
tected by Western blotting after SDS-PAGE on an 8% gel. Lanes 
1 and 3: total extracts from 0.05 OD6oo U of cells. Lanes 2 and 4: 
material bound to glutathione  beads from 0.4 006o o U of cells. 
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to the Golgi. (A) Pulse-chase analysis of CPY in a sed4-A1 strain 
(CKY251, lanes 1-6) or a wild-type strain (CKY252, lanes 7--12). 
Cells grown at 38°C were pulse labeled with [35S]methionine for 5 
min. The label was chased for the times indicated. The different 
forms of CPY were immunoprecipitated from extracts and visual- 
ized on a phosphorlmager  after SDS-PAGE. (B) Determination 
of kinetic parameters. The amount of radiolabeled pl CPY and 
total  CPY was quantitated  for each time point using the Phos- 
phorlmager software. The ratio pl CPY/total CPY gives the half- 
life of pl from a linear curve-fit on a semilogarithmic plot using 
Cricket graph (v. 1.0). The half-life of pl in a sed4-A1 strain is 1.6- 
fold >  wild-type in the experiment shown. Similar results were 
obtained in four independent experiments. 
secretory pathway have been found among genes required 
for protein translocation across the ER membrane (Roth- 
blatt et al.,  1989),  genes required for vesicle formation at 
the ER (Kaiser and Schekman, 1990),  genes required for 
vesicle fusion with the Golgi complex (Kaiser and Schek- 
man, 1990; Newman et al.,  1987),  and genes required for 
fusion  of secretory vesicles  with  the  plasma  membrane 
(Salminen  and  Novick, 1987).  Because such interactions 
have  only been  detected  between  genes  that  affect  the 
same step of the pathway, systematic tests for synthetic le- 
thality can often define the step where a gene product acts. 
To test the interactions of sed4-A1, a  URA3-marked sed4- 
A1 strain was crossed to a panel of Ts secretion mutants. 
The temperature  sensitivity of mutations in each of four 
genes required for vesicle formation at the ER (secl2-4, 
sec13-1, sec16-2,  sec23-1) was significantly increased when 
combined with sed4-AI::URA3  (Table  IV).  Importantly, 
these effects were specific for vesicle formation functions 
since sed4-A1 did not increase the temperature sensitivity 
of the mutants required for vesicle fusion (secl 7-1, sec18-1, 
sec22-3,  Table IV, and not shown) or any other secretion 
mutations (sec20-1,  sec21-1,  sec2-41,  sec4-8,  secT-l, sec8-9, 
not shown).  This  pattern  of synthetic lethal  interactions 
shows that  only defects in  vesicle formation were  made 
more severe by the absence of Sed4p, and therefore points 
to a role for SED4 in vesicle formation at the ER. 
Isolation of sed4 as an Early Secretory Pathway Mutant 
Perhaps the most convincing demonstration that SED4 is 
Table IV. Deletion of SED4 Exacerbates  the Growth Defect of 
Mutants Defective  in Vesicle Formation 
Genotype  Incubation  temperature 
28  °  30  °  33 ° 
Vesicle formation 
sec12-4  +  +  +  +  - 
sec12-4  sed4-A1:  : URA3  4-  -  - 
sec13-1  +  +  +  +  +  - 
sec13-1  sed4-AI::URA3  +  +_  - 
sec16-2  +  +  +  +-  - 
secl6-2  sed4-AI::URA3  4-  _  _ 
sec23-1  +  +  +  -  - 
sec23-1  sed4-AI::URA3  -  -  - 
Vesicle fusion 
secl7-1  +++  +++  + 
sec17-1  sed4-AI::URA3  +  +  +  +  +  +  +_ 
secl8-1  +  -  - 
sec18-1  sed4-AI::URA3  +  -  - 
Growth of single colonies  on YPD after 24-48 h.  + + +, growth comparable to wild 
type;  -, no growth. 
important for ER to Golgi transport came from the isola- 
tion of a sed4 mutant in a general screen for new secretion 
mutants.  We examined  a  collection of 1,800  random Ts 
mutants for accumulation of the ER forms of CPY and in- 
vertase by Western blotting (Holzmacher, E., and C. A. 
Kaiser,  unpublished  data).  After backcrossing and  com- 
plementation testing, Ts mutations in ~15 new genes re- 
quired  for ER to  Golgi transport  have  been  identified. 
Segregation analysis of one of these mutants, designated 
EH874, revealed that its growth and secretion defect was 
caused by mutations  in two unlinked  genes.  Analysis of 
crosses of EH874  to wild  type showed that  the  double- 
mutant segregants were Ts at 38°C, one of the single mu- 
tants was Ts at 41°C, and the other single mutant showed 
no growth defect. The mutation that caused temperature 
sensitivity at 41°C was shown to be an allele of SED4 be- 
cause it failed to complement the growth defect of sed4-A1 
at  41°C and was  completely linked  to sed4-A1  in  tetrad 
analysis. This allele was designated sed4-1  and in all  the 
phenotypic tests we performed behaved the same as sed4- 
A1. The other mutation in EH874 was phenotypically si- 
lent on its own, but was needed to confer temperature sen- 
sitivity on sed4-1.  Because SAR1  on a  low copy plasmid 
complemented the temperature  sensitivity of EH874, we 
suspected that the second mutation might be an allele of 
SAR1. Linkage to SAR1 was tested by crossing a sed4-A1 
strain  in which the  SAR1  locus was marked with  URA3 
(CKY296) to EH874. Tetrad analysis of the resulting dip- 
loids demonstrated that the mutation that caused temper- 
ature sensitivity was tightly linked to SAR1. The effect of 
this  allele,  designated sarl-5,  on growth and secretion is 
shown in Fig. 9. sarl-5 alone had no growth or secretion 
defect,  whereas  sarl-5  combined  with  sed4-AI::URA3 
showed a  severe growth defect and a  complete block in 
transport of CPY to the Golgi complex at 38°C. The sim- 
plest explanation for these results is that Sed4p is needed 
for efficient use of Sarlp, and that in the absence of Sed4p 
the subtle defect caused by the sarl-5 mutation produces a 
strong secretion defect. 
The sarl-5  allele was recovered from the chromosome 
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SAR1  causes a Ts growth  and  secretion  defect. (A) Wild-type 
(CKY291),  sed4-AI::URA3  (CKY292), sarl-5  sed4-AI::URA3 
(CKY293), and sarl-5 (CKY294) cells were spotted on rich me- 
dium and incubated for 40 h at 24 or 38°C. (B) CPY transport in 
the strains shown in A, Cells were grown in YPD at 30°C, shifted 
to 38°C for 2 h, and pulse labeled with [35S]methionine for 5 min. 
The label was chased for the  times indicated and  the different 
forms of CPY were immunoprecipitated  from extracts, resolved 
by SDS-PAGE, and imaged on a Phosphorlmager. 
by gap repair of a SAR1 plasmid. The DNA sequence of 
sarl-5 revealed a change from G to T at nucleotide 533, re- 
placing methionine 41 with isoleucine. Methionine 41 oc- 
curs in Sarl  proteins from all  organisms examined so far 
and is  located in  a  highly conserved region immediately 
following the G1 guanine nucleotide-binding domain and 
preceding the putative effector-binding domain (Kuge et 
al.,  1994).  Mutations in this region have not been previ- 
ously characterized  in  either  Sarlp  or its  closest  homo- 
logue Arflp. 
sed4-A1 sarl-5 Double Mutant Accumulates ER 
Membranes but Not Vesicles 
The finding that deletion of SED4 in a sarl-5 background 
causes a Ts ER to Golgi transport defect allowed us to ex- 
amine in more detail  the  step at which Sed4p functions. 
Mutants  that  block ER  to  Golgi complex  transport  fall 
into two morphological classes: mutants defective in fusion 
of ER-derived vesicles with the Golgi complex accumulate 
ER  membranes  and  a  large  number  of 50-nm  vesicles, 
whereas  mutants  defective in  vesicle formation accumu- 
late  only ER membranes  (Kaiser  and  Schekman,  1990). 
We examined the morphology of the sed4-AI::URA3 sarl-5 
mutant after growth at 38°C for 2 h to impose a complete 
block in  ER to  Golgi transport  (see  Fig.  9).  Cells  were 
fixed  with  potassium  permanganate  to  highlight  mem- 
branes and were viewed by electron microscopy, sed4-Al:: 
URA3 sarl-5 double-mutant cells  accumulated excess ER 
membranes, visible as extra layers of membrane through- 
out  the  cell  (Fig.  10).  To  determine  whether  sed4-Al:: 
URA3  sarl-5  cells  also  accumulated  50-nm  vesicles,  we 
counted  vesicles  in  random  cell  sections.  The  average 
number of vesicles per cubic micrometers cell volume in 
sed4-AI::URA3  sarl-5  cells  was  7.4  -  1.1. This  value  is 
Figure  10.  A  sed4-A1 sarl-5  double  mutant  accumulates  ER 
membranes,  but not vesicles. Electron  micrograph  of sed4-Al:: 
URA3 sarl-5 (CKY293) grown at 25°C and shifted to 38°C for 2 h. 
Membranes were stained with potassium permanganate. Arrows, 
excess ER. Bar, 1 Ixm. 
similar to that previously reported for other mutants de- 
fective in vesicle formation (Kaiser and Schekman, 1990). 
To establish  our ability to detect vesicles in  this  experi- 
ment, we counted vesicles in a mutant defective in vesicle 
fusion (sec17-1) that was grown at the restrictive tempera- 
ture and was fixed for microscopy in parallel. As expected, 
the sec17-1 mutant accumulated vesicles (19.8  _+ 2.2 vesi- 
cles/p,m 3 cell volume). This result implies that the sed4-Al:: 
URA3 sarl-5 double-mutation blocks vesicle formation at 
the  ER,  and  is  consistent  with  the  genetic  interactions 
between SED4 and vesicle formation genes and with the 
localization  of Sed4p  to  the  ER  membrane,  but  not  to 
vesicles. 
sarl-5 Mutation Disrupts Interaction of SAR1 with 
SEC16 but Not SECI2 
An important test for SAR1 function is the ability to sup- 
press mutations in other SEC genes.  SAR1  was first iso- 
lated  because  overexpression of SAR1  suppresses  secl2 
mutations  (Nakano  and  Muramatsu,  1989).  Overexpres- 
sion of SAR1  also suppresses secl6 and sec23 mutations, 
although the mechanistic relationship to secl2 suppression 
is not known (Nakano and Muramatsu, 1989; Oka and Na- 
kano, 1994). To explore the nature of the sarl-5 mutation, 
we tested sarl-5 expressed from either a low centromere 
or a high (21~) copy plasmid for the ability to suppress dif- 
ferent sec mutations. The sarl-5 mutation disrupted the in- 
teraction of SAR1 with SEC16 and SEC23, since sarl-5 on 
either low or high copy plasmids did not suppress secl6-2 
or sec23-1  mutations  (Table  V).  In contrast,  sarl-5  sup- 
pressed the temperature-sensitivity of secl2-4 to the same 
degree as wild-type SAR1  (Table V). Thus, the sarl-5 al- 
lele  allowed  the  function  of SAR1  needed  to  suppress 
secl2 mutations to be distinguished from the function(s) 
needed to suppress secl6 and sec23 mutations. 
In tests of sarl-5 for synthetic lethal interactions, sarl-5 
exacerbated the temperature sensitivity of secl6-2, secl3-1, 
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Mutants 
Genotype  Incubation temperature 
24 °  27 °  30 °  33 °  38 ° 
sec12-4  +++  +++  +  -  - 
sec12-4  sarl-5  +  +  +  +  +  +  +  -  - 
sec12-4(pSAR1)  +++  +++  +++  +++  +++ 
sec12-4(psar1-5)  +++  +++  +++  +++  +++ 
secl3-1  +++  +++  ++  -  - 
sec13-1  sarl-5  +  +  +  +-  -  -  - 
sec16-2  +  +  +  +  +  +  +-  -  - 
secl6-2  sarl-5  +  +  +  +-  -  -  - 
sec16-2  (pSAR1)  +  +  +  +  +  +  +  +  +  +  - 
sec16-2  (psarl-5)  +++  +++  +-  -  - 
sec23-1  +++  +++  -  -  - 
sec23-1  sarl-5  +  +  +  +  -  -  - 
sec23-1  (pSAR1)  +++  +++  ++  -  - 
sec23-1  (psarl-5)  +  +  +  +  +  +  -  -  - 
pSARI is pRH259 or pRH280, psar1-5 is pRH262 or pRH279. Growth of single colo- 
nies on YPD after 24-48 h. + + +, growth comparable to wild type;  -, no growth. 
and sec23-1  (and of sed4-A1  as described above), but had 
no effect on the growth of sec12-4 (Table IV). Again, these 
results indicate that SAR1 has at least two different func- 
tions.  One  function  involves  interaction  with  SED4, 
SEC16,  and SEC23  and is disrupted by sarl-5, while the 
other function involves interaction with SEC12 and is not 
affected by sarl-5. 
Discussion 
The major conclusion of this study is that SED4 encodes 
an important, but not essential, component of the machin- 
ery that assembles transport vesicles at the ER membrane. 
This conclusion rests on five findings.  (1) Strains with a 
chromosomal deletion of SED4 exhibit a  twofold reduc- 
tion in the rate of transport of the marker protein CPY 
from the ER to the Golgi complex. (2) The cytosolic do- 
main  of Sed4p binds to the  COOH-terminal domain of 
Sec16p,  an  ER  and  vesicle protein  that  is  required  for 
transport vesicle budding in vivo. (3) Sed4p is located in 
the ER membrane but not in vesicles, and therefore bind- 
ing to Sec16p must take place on the ER membrane. (4) 
Increased dosage of SED4 suppresses sec16 mutations. (5) 
Deletion of SED4 exacerbates mutations in genes known 
to participate in vesicle budding (SEC16, SEC12, SEC13, 
SEC23,  and  SAR1),  but  not  mutations  that  affect later 
steps in the secretory pathway. The interaction with SAR1 
is particularly striking since the sarl-5  mutation alone is 
phenotypically silent,  but  when  combined with  sed4-A1 
shows a strong secretion block. 
An important clue to the mechanism of SED4 function 
is  the  binding  of the  cytosolic domain  of Sed4p  to the 
COOH-terminal domain of Sec16p. This interaction was 
detected both by two-hybrid assay and by binding experi- 
ments in cell extracts where the two interacting domains 
were expressed as soluble proteins. An internal control for 
the  specificity  of  the  interaction  between  Sed4p  and 
Sec16p is provided by comparing binding of Sec16p to the 
cytosolic domains of Sed4p and Secl2p. The binding that 
we observe is specific to Sed4p because the cytosolic do- 
main of Secl2p, which must have a similar structure to the 
cytosolic domain of Sed4p, does not interact with Secl6p 
by either two-hybrid or solution-binding assays. Further- 
more,  two-hybrid  tests  between  Sed4p  and  regions  of 
Secl6p other than the COOH-terminal domain gave no 
interaction and a deletion that removed 250 amino acids 
from the COOH terminus of Secl6p disrupted the ability 
to interact with Sed4p (not shown). These results show a 
specific association between the cytosolic domain of Sed4p 
and  the  COOH-terminal  domain of Secl6p.  Since both 
proteins are located at the ER membrane, this is presum- 
ably where they interact. 
Genetic tests provide strong evidence that SED4 is im- 
portant for the proper function of SEC16.  When vesicle 
formation is impaired by sec16 mutation, increased dosage 
of SED4 restores function, whereas deletion of SED4 in- 
creases  the  severity of the  defect.  Since  the  activity of 
SEC16 varies according to both increased and decreased 
dosage of SED4, and since Sed4p binds to Secl6p, we con- 
clude that  SED4  is  almost  certainly needed  for proper 
function of SEC16 in vesicle formation. SAR1  shows ge- 
netic interactions with SEC16 that are similar to the ones 
observed between SED4 and SEC16. Increased dosage of 
SAR1  suppresses  sec16  mutations  (Nakano  and  Mura- 
matsu, 1989), and sec16-2 is lethal at 27°C when combined 
with sarl-5.  SAR1  also interacts genetically with SED4. 
We show that increased dosage of SAR1  suppresses the 
temperature  sensitivity  caused  by  sed4  deletion,  while 
combination of sarl-5 and sed4-1 causes a strong transport 
block. These multiple genetic interactions argue that the 
functions of Secl6p, Sed4p, and Sarlp are closely linked. 
How the interactions of these proteins are coupled to 
vesicle morphogenesis can be inferred from what we know 
of their location with respect to the forming vesicle. Three 
classes of proteins that participate in vesicle budding are 
defined by the dissection of the membrane and cytosolic 
requirements for the reconstituted budding reaction and 
by  localization  experiments  based  on  cell  fractionation 
and immunofluorescence. The first class is associated with 
the ER membrane, but is not incorporated into vesicles, 
and therefore probably functions in the ER membrane be- 
fore  completion  of the  vesicle.  Representatives  of this 
class are Sec12p (Rexach and Schekman, 1991; Barlowe et 
al., 1994) and Sed4p, as shown here. The second class, rep- 
resented by the  COPII  proteins Secl3p/Sec31p, Sec23p/ 
Sec24p, and Sarlp (Barlowe et al.,  1994) can be recruited 
from the cytosol to form a coat on the budded vesicles. In 
the accompanying paper, we show that Sec16p represents 
a third class of vesicle-forming proteins that is tightly asso- 
ciated with the ER and is also incorporated into the vesicle 
coat. 
From these localization studies, and from the genetic in- 
teractions and binding studies, we have developed a model 
for the function of Sed4p, Secl6p, Sec23p, and Sarlp in the 
early steps of vesicle assembly (Fig. 11). Because Secl6p is 
on both the ER and on vesicles it may serve as a scaffold 
for incorporation of soluble coat proteins into the vesicle. 
In the accompanying paper we show that the COPII pro- 
tein,  Sec23p,  binds  to  the  COOH-terminal  domain  of 
Sec16p.  The  genetic  interactions  between  SEC16  and 
The Journal of Cell Biology, Volume  131,  1995  336 Figure 11.  Proposed protein interactions  early in vesicle forma- 
tion. Interaction of Sarlp with Secl6p, Sec23p, and Sed4p (1) is 
interrupted by sarl-5. Interaction of Sarlp with Secl2p (2) is not 
affected by sarl-5.  Interaction of Secl6p with Sed4p and Sec23p 
is based on genetic interactions and binding studies. 
SAR1 are consistent with Sec16p also being a binding site 
for Sarlp. This proposed association of Sarlp with a com- 
plex of Secl6p and Sec23p is further supported by the ob- 
servation  that  Sec23p  stimulates  Sarlp  GTPase  activity 
(Yosihisha et al.,  1993). The function of Sed4p may be to 
promote the assembly or increase the stability of a nascent 
vesicle  coat  complex that  includes  Secl6p,  Sec23p,  and 
Sarlp. This would explain why deletion of SED4 exacer- 
bates the transport defect of sarl-5, secl6, and sec23 muta- 
tions,  and  is  consistent  with SED4  being a  nonessential 
gene. 
A  specific function for SED4,  suggested  by sequence 
similarity to SEC12, would be to stimulate guanine-nucle- 
otide  exchange  on  Sarlp.  The  NH2-terminal domain  of 
Sec12p has been shown to have such activity (Barlowe and 
Schekman, 1993), but parallel experiments using the par- 
tially purified NHe-terminal domain of Sed4p did not show 
Sarlp-specific nucleotide exchange activity (Barlowe, C., 
personal communication). Although Sed4p does not have 
guanine-nucleotide exchange activity by itself, the com- 
plex between Sed4p and Secl6p may have this acti.vity. To 
explore this possibility, we tested the soluble complex be- 
tween the NH2-terminal domain of Sed4p and COOH-ter- 
minal  domain  of Sec16p for the  ability to  stimulate  ex- 
change of GTP for GDP by Sarlp. The complex was not 
active, but the truncations of Sed4p and Secl6p used to 
produce a  soluble complex could have disrupted the ca- 
pacity to associate with Sarlp. A  more direct biochemical 
test of the interaction of Sarlp with Secl6p and Sed4p will 
depend on our ability to extract from membranes an active 
complex of these proteins. 
Our data, together with the homology between Sed4p 
and Secl2p, suggest a role for Sed4p in the recruitment of 
Sarlp to a vesicle formation compex. Secl2p has been pro- 
posed to act similarly in the initial phases of vesicle forma- 
tion by recruiting Sarlp to the membrane (d'Enfert et al., 
1991b). However, our tests for functional overlap between 
SED4 and SEC12 show that these genes perform different 
functions.  Increased dosage  of SED4  does not  suppress 
sec12 mutations and increased dosage of SEC12 does not 
suppress  the  temperature  sensitivity  of  sed4  deletions. 
Moreover,  increased  dosage  of  SED4  suppresses  sec16 
mutations, but parallel tests show no effect of increased 
dosage of SEC12 on secl6. The biochemical properties of 
the NH2-terminal domains of Secl2p and Sed4p are also 
different: the NH2-terminal domain of Sed4p binds to the 
COOH-terminal domain of Secl6p, while no binding was 
detected using the corresponding domain of Secl2p. 
One way to reconcile the apparently contradictory as- 
pects of the relationship between SED4 and SEC12 would 
be to postulate that SAR1 becomes engaged in vesicle for- 
mation  through  two  functionally independent pathways, 
one mediated by SEC12 and the other mediated by SED4 
and SEC16. A  genetic test of this idea would be to identify 
mutations  in  SAR1  that  affect one pathway but not the 
other. The sarl-5 mutation appears to have this property 
as  shown  by tests  for dosage-dependent  suppression  of 
sec12 and sec16 mutations. Increased dosage of sarl-5 does 
not suppress sec16-2, indicating that the mutation dimin- 
ishes the effectiveness of Sarlp to function with Sec16p. 
However, increased dosage of sarl-5 does suppress sec12 
mutations  as  effectively as  wild-type SAR1,  showing no 
negative effect of sarl-5 on the interaction of Sarlp with 
Secl2p. Moreover, sarl-5 exacerbates sec16 mutations, but 
has no effect on sec12 mutations, further supporting the 
idea that SAR1 engages in two independent processes, and 
that sarl-5 selectively disrupts the processes that involve 
SEC16.  The two ways that SAR1 functions in vesicle for- 
mation  as distinguished  by the sarl-5  mutation  are out- 
lined in Fig. 11. 
The  view  suggested  by our  work  is  that  Sec16p  and 
Sed4p together may constitute a docking site needed to re- 
cruit Sarlp and coat proteins such as Sec23p to a nascent 
vesicle. Models for the formation of other coated vesicles 
have a similar outline. The binding of coatomer in forma- 
tion of intra-Golgi transport vesicles and of AP-1 in for- 
mation of clathrin-coated vesicles have both been shown 
to depend on the action of the small GTP-binding protein, 
ADP-ribosylation factor (Donaldson et al., 1992; Helms et 
al., 1993; Stamnes and Rothman, 1993; Traub et al., 1993). 
These same studies showed that assembly of both types of 
vesicle also requires Golgi membrane factors which pre- 
sumably act as docking proteins for both ADP-ribosyla- 
tion factor and coat subunits.  The putative docking pro- 
teins for the Golgi complex have not yet been identified. 
We propose that Sed4p and Sec16p carry out this function 
at the ER membrane. 
Knowledge of the interactions between SEC16,  SED4, 
SAR1, and SEC23 offers a way to study the subunit associ- 
ations in the early steps of ER vesicle assembly free from 
the inherent biochemical complexity of the membrane. If 
soluble Secl6p can be obtained in an active form either as 
a recombinant protein or by extraction from membranes, 
it should be possible to develop assays in solution for the 
subunit assembly steps delineated here. 
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